Article-30(3) opinions

  • Email
  • Help

This pages lists the opinions drawn up by the Committee for Medicinal Products for Veterinary Use (CVMP) on any scientific matter related to the evaluation of medicines for use in animals. The Committee must draw up such an opinion at the request of the Executive Director of the European Medicines Agency or of the European Commission. It may also draw up an opinion following a request from a Member State.

Where the scientific issue concerns both human and veterinary medicines, the Committee may adopt a common opinion with the Committee for Medicinal Products for Human Use (CHMP).

Requests for this type of scientific opinion fall under Article 30(3) of Regulation (EC) No 726/2004.

Table of contents


Potential risk for the consumer resulting from the use of lidocaine in food producing species

Back to top

Risks to vultures and other necrophagous bird populations in the Union in connection with the use of veterinary medicinal products containing the substance diclofenac

Back to top

Document(s) Language Status First published Last updated Effective Date
CVMP assessment report under Article 30(3) of Regulation (EC) No 726/2004 on the risk to vultures and other necrophagous bird populations in the European Union in connection with the use of veterinary medicinal products containing the substance diclofenac (English only) adopted 2014-12-12    
Opinion of the Committee for Medicinal Products for Veterinary Use pursuant to Article 30(3) of Regulation (EC) No 726/2004 - On the risk to vultures and other necrophagous bird populations in the European Union in connection with the use of veterinary medicinal products containing the substance diclofenac (English only)   2014-12-12    
Overview of comments received on public consultation regarding the request to the European Medicines Agency from the European Commission for a scientific opinion regarding the risks to vultures and other necrophagous bird populations in the Union in connection with the use of veterinary medicinal products containing the substance diclofenac (English only)   2014-12-12    
Consultation procedure - Public consultation regarding the request to the European Medicines Agency from the European Commission for a scientific opinion regarding the risks to vultures and other necrophagous bird populations in the Union in connection with the use of veterinary medicinal products containing the substance diclofenac (English only) draft: consultation closed 2014-09-12    
Request for an opinion regarding the risks to vultures and other necrophagous bird populations in the Union in connection with the use of veterinary medicinal products containing the substance diclofenac (English only)   2014-09-12    
Template for comments - Public consultation regarding the request to the European Medicines Agency from the European Commission for a scientific opinion regarding the risks to vultures and other necrophagous bird populations in the Union in connection with the use of veterinary medicinal products containing the substance diclofenac (English only)   2014-09-12    

Dapsone as an impurity in veterinary medicinal products containing sulphamethoxazole or other sulphonamides

Back to top

Retrovirus RD114 in live attenuated vaccines for use in animals

Back to top